“…Vasospasm is a reasonable mechanism, since it would explain reports of the effi cacy of vasodilating drugs given prophylactically to patients who experienced a previous episode of chest pain during 5-FU treatment 5,6 . Angina pectoris, acute myocardial infarction, congestive heart failure, cardiomyopathy, myopericarditis, ventricular and supraventricular tachycardia, prolonged QT interval, sudden death, cardiogenic shock and coronary dissection are counted among cardiotoxic eff ects of 5-FU 2 .…”